Emerging in the arena of weight management management, retatrutide is a different strategy. Unlike many available medications, retatrutide works as a twin agonist, simultaneously targeting both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) sensors. The dual engagement encourages several helpful effects, like imp